Literature DB >> 25934778

Evaluation of CTA, time-resolved 4D CE-MRA and DSA in the follow-up of an intracranial aneurysm treated with a flow diverter stent: Experience from a single case.

Georgios Kapsas1, Caterina Budai2, Francesco Toni3, Francesco Patruno2, Anna Federica Marliani4, Marco Leonardi5, Luigi Cirillo5.   

Abstract

Endovascular treatment of giant, fusiform and dissecting aneurysms with flow diverter stents is becoming more and more popular. However, very few studies on the follow-up have been published. We describe a patient with a dissecting aneurysm of the right vertebral artery treated with flow diverter stent placement. The patient was followed up with CT angiography (CTA), time-resolved contrast-enhanced MR angiography (CE-MRA) and digital subtraction angiography (DSA). CTA had false negative results in two instances, whereas time-resolved CE-MRA and DSA were the most accurate in depicting the residual flow in the aneurysmal sac. However, in the case of DSA the demonstration of residual flow proved quite difficult and required a very thorough examination with oblique projections. Our 2.5-year experience with this patient led us to believe that time-resolved CE-MRA is a valuable tool in the follow-up of flow diverter-treated stents.
© The Author(s) 2015 Reprints and permissions:]br]sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  CT angiography; Intracranial aneurysm; contrast-enhanced MR angiography; digital subtraction angiography; flow diverter

Mesh:

Substances:

Year:  2015        PMID: 25934778      PMCID: PMC4757195          DOI: 10.15274/inr-2014-10092

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  10 in total

1.  Treatment of intracranial aneurysms using flow-diverting silk stents (BALT): a single centre experience.

Authors:  M Leonardi; L Cirillo; F Toni; M Dall'olio; C Princiotta; A Stafa; L Simonetti; R Agati
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

2.  3T MRI in the Evaluation of Brain Aneurysms Treated with Flow-Diverting Stents: Preliminary Experience.

Authors:  F Toni; A F Marliani; L Cirillo; S Battaglia; C Princiotta; M Dall'olio; L Simonetti; M Leonardi
Journal:  Neuroradiol J       Date:  2009-12-14

3.  MR angiography at 3T versus digital subtraction angiography in the follow-up of intracranial aneurysms treated with detachable coils.

Authors:  Charles B L M Majoie; Marieke E Sprengers; Willem Jan J van Rooij; Cristina Lavini; Menno Sluzewski; Jeroen C van Rijn; Gerard J den Heeten
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

4.  Contrast-enhanced time-resolved MRA for follow-up of intracranial aneurysms treated with the pipeline embolization device.

Authors:  S R Boddu; F C Tong; S Dehkharghani; J E Dion; A M Saindane
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-03       Impact factor: 3.825

5.  Time-of-flight MR angiography targeted to coiled intracranial aneurysms is more sensitive to residual flow than is digital subtraction angiography.

Authors:  Naoaki Yamada; Katsuhiko Hayashi; Kenichi Murao; Masahiro Higashi; Koji Iihara
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

6.  Characterization of aneurysm remnants after endovascular treatment: contrast-enhanced MR angiography versus catheter digital subtraction angiography.

Authors:  R Agid; R A Willinsky; S-K Lee; K G Terbrugge; R I Farb
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

7.  Comparison of 3D TOF-MRA and 3D CE-MRA at 3T for imaging of intracranial aneurysms.

Authors:  Mario Cirillo; Francesco Scomazzoni; Luigi Cirillo; Marcello Cadioli; Franco Simionato; Antonella Iadanza; Miles Kirchin; Claudio Righi; Nicoletta Anzalone
Journal:  Eur J Radiol       Date:  2013-09-12       Impact factor: 3.528

8.  Immediate intracranial aneurysm occlusion after embolization with detachable coils: a comparison between MR angiography and intra-arterial digital subtraction angiography.

Authors:  B Lubicz; M Levivier; N Sadeghi; P Emonts; D Balériaux
Journal:  J Neuroradiol       Date:  2007-07       Impact factor: 3.447

9.  The use of flow-diverting stents in the treatment of giant cerebral aneurysms: preliminary results.

Authors:  L Cirillo; M Dall'olio; C Princiotta; L Simonetti; A Stafa; F Toni; M Leonardi
Journal:  Neuroradiol J       Date:  2010-04-20

10.  CE-MRA for follow-up of aneurysms post stent-assisted coiling.

Authors:  R Agid; M Schaaf; Ri Farb
Journal:  Interv Neuroradiol       Date:  2012-09-10       Impact factor: 1.610

  10 in total
  5 in total

1.  Aneurysmal and Perianeurysmal Changes After Endovascular Treatment: from Inflammation to Microbleed. A Case Report.

Authors:  L Cirillo; F Toni; M Dall'Olio; C Princiotta; M Leonardi
Journal:  Clin Neuroradiol       Date:  2015-07-31       Impact factor: 3.649

Review 2.  Endovascular treatment of cerebral aneurysms using flow-diverter devices: A systematic review.

Authors:  Francesco Briganti; Giuseppe Leone; Mariano Marseglia; Giuseppe Mariniello; Ferdinando Caranci; Arturo Brunetti; Francesco Maiuri
Journal:  Neuroradiol J       Date:  2015-08-27

3.  Comparison of postsurgical clinical sequences between completely embolized and incompletely embolized patients with wide nicked intracranial aneurysms treated with stent assisted coil embolization technique: A STROBE-compliant study.

Authors:  Zi-Qiang Cai; Shi-Hong Chai; Xiang-Lei Wei; Ke-Zeng You; Jiang Li; Ding-Mei Zhang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

4.  Diagnostic Value of Low-Dose 256-Slice Spiral CT Angiography, MR Angiography, and 3D-DSA in Cerebral Aneurysms.

Authors:  Yan Feng; Sheng Jie Shu
Journal:  Dis Markers       Date:  2020-01-13       Impact factor: 3.434

5.  Application of computed tomography angiography for evaluating clinical morphology in intracranial aneurysms - monocentric study.

Authors:  Ru-de Sui; Chun-Guo Wang; Dong-Wei Han; Xiu-Qing Zhang; Qing Li; Chun-Fu Xu; Pi-Bao Gong
Journal:  J Int Med Res       Date:  2019-12-29       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.